PriceTargets.com logo

Chemours - CC Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $21.56
  • Forecasted Upside: 78.44%
  • Number of Analysts: 9
  • Breakdown:
  • 0 Sell Ratings
  • 4 Hold Ratings
  • 5 Buy Ratings
  • 0 Strong Buy Ratings
$12.08 As of 05/5/2025 04:59 PM ET
▼ -0.42 (-3.36%)

This chart shows the closing price for CC by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
MarAprMay$12.08Closing price on 05/05/25:
Get New Chemours Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CC

Analyst Price Target is $21.56
▲ +78.44% Upside Potential
This price target is based on 9 analysts offering 12 month price targets for Chemours in the last 3 months. The average price target is $21.56, with a high forecast of $28.00 and a low forecast of $15.00. The average price target represents a 78.44% upside from the last price of $12.08.

This chart shows the closing price for CC for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart
5/248/2410/241/255/255/26$6.71$13$19$26$32Closing price on 05/05/25: $12.08High$28.00Average$21.56Low$15.00




Current Consensus is Moderate Buy

The current consensus among 9 investment analysts is to moderate buy stock in Chemours. This rating has held steady since March 2025, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 7 hold ratings
  • 1 sell ratings
Ratings as of
11/12/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 6 hold ratings
  • 1 sell ratings
Ratings as of
2/10/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 6 hold ratings
  • 0 sell ratings
Ratings as of
5/10/2024
  • 0 strong buy ratings
  • 3 buy ratings
  • 5 hold ratings
  • 0 sell ratings
Ratings as of
8/8/2024
  • 0 strong buy ratings
  • 3 buy ratings
  • 5 hold ratings
  • 0 sell ratings
Ratings as of
11/6/2024
  • 0 strong buy ratings
  • 4 buy ratings
  • 5 hold ratings
  • 0 sell ratings
Ratings as of
2/4/2025
  • 0 strong buy ratings
  • 5 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
4/5/2025
  • 0 strong buy ratings
  • 5 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
5/5/2025

Latest Recommendations

  • 0 strong buy ratings
  • 5 buy ratings
  • 4 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
4/15/2025MizuhoSet Target$15.00
4/14/2025Truist FinancialLower TargetBuy ➝ Buy$27.00 ➝ $22.00
4/1/2025BarclaysLower TargetEqual Weight ➝ Equal Weight$19.00 ➝ $16.00
3/27/2025MizuhoUpgradeNeutral ➝ Outperform$19.00 ➝ $19.00
2/24/2025BarclaysLower TargetEqual Weight ➝ Equal Weight$23.00 ➝ $19.00
2/19/2025BMO Capital MarketsLower TargetOutperform ➝ Outperform$34.00 ➝ $27.00
1/28/2025Truist FinancialInitiated CoverageBuy$27.00
1/13/2025Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$25.00 ➝ $22.00
1/7/2025MizuhoLower TargetNeutral ➝ Neutral$22.00 ➝ $21.00
1/7/2025The Goldman Sachs GroupLower TargetNeutral ➝ Neutral$24.00 ➝ $21.00
12/12/2024Royal Bank of CanadaReiterated RatingOutperform ➝ Outperform$25.00 ➝ $25.00
11/6/2024Royal Bank of CanadaLower TargetOutperform ➝ Outperform$28.00 ➝ $25.00
11/5/2024Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$30.00 ➝ $25.00
11/5/2024BarclaysBoost TargetEqual Weight ➝ Equal Weight$21.00 ➝ $23.00
10/11/2024Royal Bank of CanadaLower TargetOutperform ➝ Outperform$35.00 ➝ $28.00
10/7/2024BMO Capital MarketsBoost TargetOutperform ➝ Outperform$30.00 ➝ $32.00
9/25/2024BarclaysLower TargetEqual Weight ➝ Equal Weight$22.00 ➝ $21.00
9/3/2024The Goldman Sachs GroupLower TargetNeutral ➝ Neutral$29.00 ➝ $23.00
8/6/2024JPMorgan Chase & Co.Lower TargetNeutral ➝ Neutral$25.00 ➝ $18.00
8/6/2024UBS GroupLower TargetBuy ➝ Buy$30.00 ➝ $28.00
8/6/2024BarclaysLower TargetEqual Weight ➝ Equal Weight$30.00 ➝ $22.00
8/6/2024BMO Capital MarketsLower TargetOutperform ➝ Outperform$35.00 ➝ $30.00
7/9/2024UBS GroupUpgradeNeutral ➝ Buy$28.00 ➝ $30.00
6/7/2024MizuhoInitiated CoverageNeutral$25.00
4/9/2024BMO Capital MarketsUpgradeUnderperform ➝ Outperform$19.00 ➝ $34.00
4/2/2024UBS GroupBoost TargetNeutral ➝ Neutral$21.00 ➝ $28.00
4/2/2024BarclaysLower TargetEqual Weight ➝ Equal Weight$32.00 ➝ $30.00
3/5/2024UBS GroupReiterated RatingBuy ➝ Neutral$37.00 ➝ $21.00
2/29/2024BMO Capital MarketsDowngradeOutperform ➝ Underperform$45.00 ➝ $19.00
12/1/2023Royal Bank of CanadaUpgradeSector Perform ➝ Outperform$28.00 ➝ $40.00
11/7/2023JPMorgan Chase & Co.Lower TargetNeutral ➝ Neutral$38.00 ➝ $26.00
10/31/2023The Goldman Sachs GroupLower TargetNeutral ➝ Neutral$35.00 ➝ $30.00
10/30/2023Royal Bank of CanadaLower TargetSector Perform ➝ Sector Perform$30.00 ➝ $28.00
10/30/2023BMO Capital MarketsLower TargetOutperform ➝ Outperform$45.00 ➝ $39.00
10/30/2023Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$33.00 ➝ $28.00
10/30/2023BarclaysLower TargetEqual Weight ➝ Equal Weight$31.00 ➝ $28.00
10/4/2023BarclaysLower TargetEqual Weight ➝ Equal Weight$40.00 ➝ $31.00
8/2/2023BMO Capital MarketsLower TargetOutperform ➝ Outperform$64.00 ➝ $53.00
8/1/2023Morgan StanleyReiterated RatingEqual Weight ➝ Equal Weight$33.00
7/31/2023Royal Bank of CanadaBoost TargetSector Perform$37.00 ➝ $40.00
7/19/2023Morgan StanleyReiterated RatingEqual Weight ➝ Equal Weight$33.00
7/11/2023BarclaysBoost Target$38.00 ➝ $40.00
6/22/2023Bank of AmericaDowngradeBuy ➝ Neutral$41.00 ➝ $37.00
6/13/2023UBS GroupBoost Target$41.00 ➝ $43.00
6/9/2023Royal Bank of CanadaBoost Target$36.00 ➝ $37.00
6/5/2023BMO Capital MarketsBoost Target$54.00 ➝ $64.00
5/1/2023Royal Bank of CanadaBoost Target$35.00 ➝ $36.00
4/28/2023Credit Suisse GroupLower Target$27.00 ➝ $25.00
2/14/2023The Goldman Sachs GroupBoost TargetNeutral$34.00 ➝ $38.00
2/13/2023CitigroupBoost TargetNeutral$33.00 ➝ $35.00
2/13/2023Royal Bank of CanadaBoost TargetSector Perform$33.00 ➝ $36.00
2/10/2023Credit Suisse GroupBoost TargetUnderperform$24.00 ➝ $27.00
1/24/2023UBS GroupUpgradeNeutral ➝ Buy$31.00 ➝ $43.00
1/11/2023UBS GroupBoost TargetNeutral$29.00 ➝ $31.00
1/11/2023Bank of AmericaUpgradeNeutral ➝ Buy$37.00 ➝ $40.00
1/10/2023Royal Bank of CanadaDowngradeOutperform ➝ Sector Perform$35.00 ➝ $33.00
12/15/2022CitigroupBoost TargetNeutral$30.00 ➝ $33.00
11/1/2022Credit Suisse GroupInitiated CoverageUnderperform$24.00
11/1/2022BarclaysBoost Target$30.00 ➝ $34.00
10/27/2022CitigroupBoost Target$30.00
10/27/2022BMO Capital MarketsLower TargetOutperform$46.00 ➝ $41.00
10/25/2022Morgan StanleyLower TargetEqual Weight$41.00 ➝ $33.00
10/13/2022The Goldman Sachs GroupInitiated CoverageNeutral$30.00
10/5/2022ArgusDowngradeBuy ➝ Hold
10/4/2022CitigroupLower Target$36.00 ➝ $27.00
9/27/2022BarclaysLower TargetEqual Weight$46.00 ➝ $30.00
9/23/2022BMO Capital MarketsLower TargetOutperform$55.00 ➝ $46.00
9/22/2022Bank of AmericaLower Target$44.00 ➝ $36.00
9/22/2022Royal Bank of CanadaLower TargetOutperform$48.00 ➝ $35.00
8/9/2022CitigroupBoost Target$36.00
8/3/2022CitigroupBoost Target$32.00 ➝ $36.00
8/1/2022Royal Bank of CanadaBoost TargetOutperform$44.00 ➝ $48.00
7/29/2022UBS GroupBoost TargetNeutral$35.00 ➝ $37.00
7/13/2022UBS GroupLower Target$105.00
6/14/2022Bank of AmericaDowngradeBuy ➝ Neutral$48.00 ➝ $44.00
5/9/2022BarclaysBoost Target$37.00 ➝ $46.00
2/15/2022Royal Bank of CanadaLower TargetOutperform$44.00 ➝ $41.00
2/14/2022JPMorgan Chase & Co.Lower TargetNeutral$35.00 ➝ $30.00
1/4/2022UBS GroupBoost TargetNeutral$34.00 ➝ $36.00
11/8/2021Royal Bank of CanadaBoost TargetOutperform$40.00 ➝ $45.00
8/3/2021Royal Bank of CanadaBoost TargetOutperform$35.00 ➝ $40.00
6/30/2021BMO Capital MarketsBoost TargetOutperform$42.00 ➝ $48.00
6/9/2021Wolfe ResearchInitiated CoverageOutperform
6/9/2021The Goldman Sachs GroupUpgradeNeutral ➝ Buy$35.00 ➝ $47.00
5/20/2021Bank of AmericaInitiated CoverageBuy$42.00
5/10/2021Morgan StanleyBoost TargetEqual Weight$30.00 ➝ $35.00
5/6/2021ArgusUpgradeHold ➝ Buy$40.00
2/17/2021CitigroupBoost Target$27.00 ➝ $29.00
2/16/2021BMO Capital MarketsBoost Target$33.00 ➝ $38.00
2/16/2021Morgan StanleyBoost TargetEqual Weight$28.00 ➝ $30.00
1/8/2021Royal Bank of CanadaUpgradeSector Perform ➝ Outperform$27.00 ➝ $35.00
12/14/2020Morgan StanleyBoost TargetEqual Weight$23.00 ➝ $28.00
12/4/2020BarclaysDowngradeOverweight ➝ Equal Weight$26.00 ➝ $28.00
11/30/2020Alembic Global AdvisorsInitiated CoverageOverweight$31.00
11/16/2020Morgan StanleyBoost TargetEqual Weight$12.00 ➝ $23.00
11/5/2020BMO Capital MarketsBoost TargetOutperform$26.00 ➝ $28.00
11/5/2020BarclaysBoost TargetOverweight$22.00 ➝ $26.00
8/4/2020CitigroupBoost TargetNeutral$16.00 ➝ $18.00
8/3/2020Royal Bank of CanadaBoost TargetSector Perform$15.00 ➝ $19.00
8/3/2020BarclaysBoost TargetOverweight$16.00 ➝ $22.00
7/9/2020UBS GroupBoost TargetNeutral$12.00 ➝ $15.00
5/8/2020UBS GroupBoost TargetNeutral$9.00 ➝ $12.00
5/7/2020SunTrust BanksBoost TargetHold$10.00 ➝ $12.00
(Data available from 5/6/2020 forward)

News Sentiment Rating

1.16 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 13 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/7/2024
  • 8 very positive mentions
  • 19 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
Mentions as of
11/6/2024
  • 18 very positive mentions
  • 11 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
12/6/2024
  • 11 very positive mentions
  • 10 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/5/2025
  • 5 very positive mentions
  • 21 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
Mentions as of
2/4/2025
  • 11 very positive mentions
  • 26 positive mentions
  • 8 negative mentions
  • 1 very negative mentions
Mentions as of
3/6/2025
  • 18 very positive mentions
  • 23 positive mentions
  • 4 negative mentions
  • 1 very negative mentions
Mentions as of
4/5/2025
  • 34 very positive mentions
  • 10 positive mentions
  • 4 negative mentions
  • 1 very negative mentions
Mentions as of
5/5/2025

Current Sentiment

  • 34 very positive mentions
  • 10 positive mentions
  • 4 negative mentions
  • 1 very negative mentions

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

Chemours logo
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging. The Thermal & Specialized Solutions segment offers of refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents. The Advanced Performance Materials segment products portfolio includes various industrial resins, specialty products, membranes, and coatings for electronics, communications, transportation, wire and cable, energy, oil and gas, and medical, and other applications under the eflon, Viton, Krytox, and Nafion brands. The company sells its products through direct and indirect channels, as well as through a network of resellers and distributors. The Chemours Company was incorporated in 2014 and is headquartered in Wilmington, Delaware.
Read More

Today's Range

Now: $12.08
Low: $12.02
High: $12.38

50 Day Range

MA: $12.79
Low: $9.59
High: $15.19

52 Week Range

Now: $12.08
Low: $9.33
High: $29.21

Volume

2,335,300 shs

Average Volume

1,873,323 shs

Market Capitalization

$1.81 billion

P/E Ratio

21.19

Dividend Yield

8.20%

Beta

1.76

Frequently Asked Questions

What sell-side analysts currently cover shares of Chemours?

The following sell-side analysts have issued stock ratings on Chemours in the last twelve months: Barclays PLC, BMO Capital Markets, JPMorgan Chase & Co., Mizuho, Morgan Stanley, Royal Bank of Canada, The Goldman Sachs Group, Inc., Truist Financial Co., and UBS Group AG.
View the latest analyst ratings for CC.

What is the current price target for Chemours?

0 Wall Street analysts have set twelve-month price targets for Chemours in the last year. Their average twelve-month price target is $21.56, suggesting a possible upside of 78.4%. UBS Group AG has the highest price target set, predicting CC will reach $28.00 in the next twelve months. Mizuho has the lowest price target set, forecasting a price of $15.00 for Chemours in the next year.
View the latest price targets for CC.

What is the current consensus analyst rating for Chemours?

Chemours currently has 4 hold ratings and 5 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for CC.

What other companies compete with Chemours?

Other companies that are similar to Chemours include Arcadium Lithium, CSW Industrials, Element Solutions, Avient and Methanex. Learn More about companies similar to Chemours.

How do I contact Chemours' investor relations team?

Chemours' physical mailing address is 1007 MARKET STREET, WILMINGTON DE, 19801. The specialty chemicals company's listed phone number is (302) 773-1000 and its investor relations email address is investor@chemours.com. The official website for Chemours is www.chemours.com. Learn More about contacing Chemours investor relations.





Receive Chemours News & Ratings Daily
Sign up to receive the latest news and ratings for Chemours and its competitors with PriceTargets.com’s free daily newsletter.